GF Xinde
Funding rounds backed by GF Xinde.
- Funding disclosed in full
- $40M
- Median round
- $40M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Degron Therapeutics Develops molecular glue degrader medicines targeting previously undruggable proteins | $40MSeries A+ | BiotechChina |